Jyseleca 100 mg and 200 mg film-coated tablets *
Company:
Gilead Sciences LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 07 May 2021
File name
Jyseleca SmPC - April 2021_1620394832.pdf
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 5.2 - Pharmacokinetic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 07 May 2021
File name
Jyseleca PIL - April 2021_1620394790.pdf
Reasons for updating
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 6 - date of revision
- Addition of information on reporting a side effect.
File name
Jyseleca Patient Alert Card (Ireland) UK-INF-2020-08-0020_1602344862.pdf
Reasons for updating
- Add New Doc
File name
Jyseleca HCP Guide (Ireland) UK-INF-2020-08-0019_1602344862.pdf
Reasons for updating
- Add New Doc
Updated on 05 October 2020
File name
Jyseleca PIL -Sep 2020_1601905338.pdf
Reasons for updating
- New PIL for new product
Updated on 05 October 2020
File name
Jyseleca SmPC -Sep 2020_1601905298.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)